S-nitrosylation of cyclin-dependent kinase 5 (Cdk5) regulates its kinase activity and dendrite growth during neuronal development

Journal of Neuroscience

Volumn 30, Issue 43, 2010, Pages 14366-14370

  Zhang, Peng ^a   Yu, Pei Chun ^a   Tsang, Anthony H K ^a   Chen, Yu ^a   Fu, Amy K Y ^a   Fu, Wing Yu ^a   Chung, Kenny K ^a   Ip, Nancy Y ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 5;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENDRITE; EMBRYO; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; HUMAN CELL; MALE; MOUSE; NERVE CELL DIFFERENTIATION; NERVE CELL GROWTH; NERVE FUNCTION; NITROSYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; RAT; SITE DIRECTED MUTAGENESIS;

ANIMALS; BIOTIN; BRAIN CHEMISTRY; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 5; CYSTEINE; DENDRITES; DNA, COMPLEMENTARY; HIPPOCAMPUS; HUMANS; MICE; NEURONS; NITROSO COMPOUNDS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT FUSION PROTEINS; TRANSFECTION;

EID: 78049351867     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3899-10.2010     Document Type: Article

References (30)

1. Bredt DS, Snyder SH (1994) Nitric Oxide: A Physiologic Messenger Molecule. Annu Rev Biochem 63:175-195.
2. Cheung ZH, Ip NY (2007) The roles of cyclin-dependent kinase 5 in dendrite and synapse development. Biotechnol J 2:949-957.
3. Cheung ZH, Fu AK, Ip NY (2006) Synaptic roles of Cdk5: implications in higher cognitive functions and neurodegenerative diseases. Neuron 50:13-18.
4. Chung KK (2006) Say NO to neurodegeneration: role of S-nitrosylation in neurodegenerative disorders. Neurosignals 15:307-313.
5. Cruz JC, Tsai LH (2004) A Jekyll and Hyde kinase: roles for Cdk5 in brain development and disease. Curr Opin Neurobiol 14:390-394.
6. Dhavan R, Tsai LH (2001) A decade of CDK5. Nat Rev Mol Cell Biol 2:749-759.
7. Fu WY, Chen Y, Sahin M, Zhao XS, Shi L, Bikoff JB, Lai KO, Yung WH, Fu AK, Greenberg ME, Ip NY (2007) Cdk5 regulates EphA4-mediated dendritic spine retraction through an ephexin1-dependent mechanism. Nat Neurosci 10:67-76. (Pubitemid 46026529)
8. Guix FX, Uribesalgo I, Coma M, Muñoz FJ (2005) The physiology and pathophysiology of nitric oxide in the brain. Prog Neurobiol 76:126-152. (Pubitemid 41242885)
9. Hisanaga S, Saito T (2003) The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator. Neurosignals 12:221-229. (Pubitemid 37548237)
10. Kamei H, Saito T, Ozawa M, Fujita Y, Asada A, Bibb JA, Saido TC, Sorimachi H, Hisanaga S (2007) Suppression of calpain-dependent cleavage of the CDK5 activator p35 to p25 by site-specific phosphorylation. J Biol Chem 282:1687-1694. (Pubitemid 47076684)
11. Kusakawa G, Saito T, Onuki R, Ishiguro K, Kishimoto T, Hisanaga S (2000) Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25. J Biol Chem 275:17166-17172. (Pubitemid 30398964)
12. Lai KO, IpNY (2009) Recent advances in understanding the roles of Cdk5 in synaptic plasticity. Biochim Biophys Acta 1792:741-745
13. Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH (2000) Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405:360-364. (Pubitemid 30337070)
14. Lipton SA, Choi YB, Sucher NJ, Chen HS (1998) Neuroprotective versus neurodestructive effects of NO-related species. Biofactors 8:33-40.
15. Mapelli M, Massimiliano L, Crovace C, Seeliger MA, Tsai LH, Meijer L, Musacchio A (2005) Mechanism of CDK5/p25 binding by CDK inhibitors. J Med Chem 48:671-679. (Pubitemid 40209090)
16. Nott A, Watson PM, Robinson JD, Crepaldi L, Riccio A (2008) S-Nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons. Nature 455:411-415.
17. Ohshima T, Hirasawa M, Tabata H, Mutoh T, Adachi T, Suzuki H, Saruta K, Iwasato T, Itohara S, Hashimoto M, Nakajima K, Ogawa M, Kulkarni AB, Mikoshiba K (2007) Cdk5 is required for multipolar-to-bipolar transition during radial neuronal migration and proper dendrite development of pyramidal neurons in the cerebral cortex. Development 134:2273-2282. (Pubitemid 47010016)
18. Otyepka M, Bártová I, Kríz Z, Koca J (2006) Different mechanisms of CDK5 and CDK2 activation as revealed by CDK5/p25 and CDK2/cyclin A dynamics. J Biol Chem 281:7271-7281. (Pubitemid 43847495)
19. Patzke H, Tsai LH (2002) Calpain-mediated cleavage of the cyclin-dependent kinase-5 activator p39 to p29. J Biol Chem 277:8054-8060. (Pubitemid 34968258)
20. Rahman MA, Senga T, Ito S, Hyodo T, Hasegawa H, Hamaguchi M (2010) S-nitrosylation at cysteine 498 of c-Src tyrosine kinase regulates nitric oxide-mediated cell invasion. J Biol Chem 285:3806-3814.
21. Reynaert NL, Ckless K, Korn SH, Vos N, Guala AS, Wouters EF, van der Vliet A, Janssen-Heininger YM (2004) Nitric oxide represses inhibitory kappaB kinase through S-nitrosylation. Proc Natl Acad Sci U S A 101:8945-8950. (Pubitemid 38781591)
22. Saito T, Onuki R, Fujita Y, Kusakawa G, Ishiguro K, Bibb JA, Kishimoto T, Hisanaga S (2003) Developmental regulation of the proteolysis of the p35 cyclin-dependent kinase 5 activator by phosphorylation. J Neurosci 23:1189-1197. (Pubitemid 36258898)
23. Song T, Hatano N, Kambe T, Miyamoto Y, Ihara H, Yamamoto H, Sugimoto K, Kume K, Yamaguchi F, Tokuda M, Watanabe Y (2008) Nitric oxide-mediated modulation of calcium/calmodulin-dependent protein kinase II. Biochem J 412:223-231. (Pubitemid 351758228)
24. Stamler JS, Toone EJ, Lipton SA, Sucher NJ (1997) (S)NO signals: translocation, regulation, and a consensus motif. Neuron 18:691-696.
25. Stroissnigg H, Trancíková A, Descovich L, Fuhrmann J, Kutschera W, Kostan J, Meixner A, Nothias F, Propst F (2007) S-nitrosylation of microtubule-associated protein 1B mediates nitric-oxide-induced axon retraction. Nat Cell Biol 9:1035-1045. (Pubitemid 47338143)
26. Tsang AH, Lee YI, Ko HS, Savitt JM, Pletnikova O, Troncoso JC, Dawson VL, Dawson TM, Chung KK (2009) S-nitrosylation of XIAP compromises neuronal survival in Parkinson's disease. Proc Natl Acad Sci U S A 106:4900-4905.
27. Wei FY, Tomizawa K, Ohshima T, Asada A, Saito T, Nguyen C, Bibb JA, Ishiguro K, Kulkarni AB, Pant HC, Mikoshiba K, Matsui H, Hisanaga S (2005) Control of cyclin-dependent kinase 5 (Cdk5) activity by glutamatergic regulation of p35 stability. J Neurochem 93:502-512. (Pubitemid 40547507)
28. Whalen EJ, Foster MW, Matsumoto A, Ozawa K, Violin JD, Que LG, Nelson CD, Benhar M, Keys JR, Rockman HA, Koch WJ, Daaka Y, Lefkowitz RJ, Stamler JS (2007) Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2. Cell 129:511-522. (Pubitemid 46660966)
29. Yasukawa T, Tokunaga E, Ota H, Sugita H, Martyn JA, Kaneki M (2005) S-nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance. J Biol Chem 280:7511-7518. (Pubitemid 40349643)
30. Zhang J, Luan CH, Chou KC, Johnson GV (2002) Identification of the N-terminal functional domains of Cdk5 by molecular truncation and computer modeling. Proteins 48:447-453. (Pubitemid 34810411)